“anti-TNF drugs”的搜索结果，显示 801-810 项，共有 6887 项

1. 神经外科- 临床试验- 妙佑医疗国际

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

2. 神经外科- 临床试验- 妙佑医疗国际

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

3. 血液科- 临床试验- 妙佑医疗国际

   ... therapy. Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer ...

4. 神经外科- 临床试验- 妙佑医疗国际

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

5. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

7. 神经科- 临床试验- 妙佑医疗国际

   Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Treatment options are then defined according to the disease burden strata. Treatment is allocated by randomisation. Patients may be allocated to one of ...

9. 心血管医学- 临床试验- 妙佑医疗国际

   ... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...

10. 血液科- 临床试验- 妙佑医疗国际

    Drugs used in chemotherapy work in different ways to stop the growth of ... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...